- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02165865
Vascularized Composite Allotransplantation of the Hand and Upper Extremity (Hand Transplant)
Vascularized Composite Allotransplantation of the Hand and Upper Extremity for the Restoration of Form and Function in Hand Amputees
Study Overview
Status
Intervention / Treatment
Detailed Description
Hand transplantation is the surgical attachment of a hand and sometimes an arm from an organ donor to a person who has previously suffered an amputation. It is similar to other organ transplants, such as a heart, liver, or kidney, in that the tissue comes from a deceased donor and therefore requires lifelong medications to prevent rejection. Hand transplantation also requires extensive hand rehabilitation to regain function of the transplanted limb.
The primary focus of the study is to perform hand transplantation using a steroid-sparing immunosuppression regimen, to closely follow outcomes for at least 2 years after the transplant, and to utilize new methods for immune system and functional recovery. The number and severity of side effects and the treatment provided will be analyzed in relation to the standard immunosuppressive drugs used. Functional and clinical outcomes will be correlated with data on quality of life.
After consultation with the study team and signing of the study consent forms, patients will undergo a thorough screening phase, including imaging, laboratory tests, age-appropriate screening, psychosocial evaluations, physical and occupational therapy (OT) screening, and tissue typing. Patients will then be selected by a formal patient selection committee meeting, based on results of screening procedures.
If found to be a good candidate for hand transplantation, the patient will be listed with the United Network for Organ Sharing (UNOS) to wait for a compatible donor. Organ donors from the surrounding region will be screened for compatibility in regards to blood type and tissue type, as well as hand size, skin color, tone, and hair patterns. Once a matching donor is located, the hand transplant team and participant will be notified.
After surgery the patient will stay in the intensive care unit for 1-3 days and then move to a regular hospital room where they will stay for 1-2 weeks. Physical therapy will begin within 2-3 days after surgery, and transplant staff will give daily information on the anti-rejection medications. After discharge from the hospital, the patient will stay locally for 3-6 months to monitor for signs of rejection and for extensive hand rehabilitation. Housing will be provided during this period by the hospital. Functional, psychological and immunological outcomes will then be closely followed for the life of the allograft.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Springfield, Illinois, United States, 62781
- Memorial Medical Center
-
Springfield, Illinois, United States, 62794-9653
- SIU Institute for Plastic Surgery
-
Springfield, Illinois, United States, 62794-9653
- Southern Illinois University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Recent (≥6 months) or remote (i.e., several decades) unilateral or bilateral upper limb loss from trauma or other causes desiring limb transplantation
- Below-shoulder amputation
- Male or female and of any race, color or ethnicity
- Aged 18-69 years
- Willing and able to understand and sign informed consent form
- No co-existing medical condition which, in the opinion of the study team, would place them at high risk for the surgical procedure, immunosuppression protocol, or functional results
- No co-existing psychosocial problems (i.e., alcoholism, drug abuse, lack of social support) or issue identified during psychosocial battery of testing
- Negative for malignancy for past 5 years
- Negative for hepatitis C virus or HIV at transplant
- Negative crossmatch with donor
- If female of child-bearing potential, negative serum pregnancy test
- If female of child-bearing potential, consent to use reliable contraception for at least one year following transplantation
- Willing and able to sign consents for tissue studies
- Willing to comply with Intermediate System (IS) and hand therapy protocols
Exclusion Criteria:
- Conditions that, in the opinion of the investigators, would place patient at unacceptably high risk for the surgical procedure, immunosuppression protocol, or functional results
- Sensitized recipients with high levels (>70%) of panel-reactive human leukocyte antigen (HLA) antibodies
- Conditions that may impact the success of the surgical procedure or increase the risk of postoperative complications including inherited coagulopathies like Hemophilia, Von-Willebrand's disease, Protein C and S deficiency, Thrombocythemias, Thalassemias, Sickle Cell disease, etc.
- Mixed connective tissue diseases and collagen diseases that may result in poor wound healing after surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: upper extremity/ hand transplantation
hand transplant on unilateral dominant hand or bilateral upper extremity amputees
|
hand transplant on unilateral dominant hand or bilateral upper extremity amputees
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
hand allograft survival
Time Frame: Transplantation through end of study period (up to 5 years)
|
Transplantation through end of study period (up to 5 years)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
hand allograft function
Time Frame: Transplantation through end of study period (up to 5 years)
|
tests, 2 point discrimination, electromyography (EMG)/nerve conduction studies, range of motion, and a functional status assessment that includes activities of daily living
|
Transplantation through end of study period (up to 5 years)
|
immunological response to hand transplantation
Time Frame: Transplantation through end of study period (up to 5 years)
|
white blood cell counts, immunosuppression serum drug levels, donor specific antigen levels, tissue biopsy Banff grades
|
Transplantation through end of study period (up to 5 years)
|
brain cortical reorganization and adaptation
Time Frame: Transplantation through end of study period (up to 5 years)
|
functional MRI
|
Transplantation through end of study period (up to 5 years)
|
psychosocial impact
Time Frame: Transplantation through end of study period (up to 5 years)
|
Flannagan QOL (quality of life) survey and the Connor-Davidson Resilience Scale (CD-RISC)
|
Transplantation through end of study period (up to 5 years)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael W Neumeister, MD, Southern Illinois University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NEU-SIUSOM-13-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Traumatic Amputation of Arm
-
VA Office of Research and DevelopmentCompleted
-
US Department of Veterans AffairsBrown University; LifespanCompletedTraumatic Amputation of ArmUnited States
-
University of MichiganWithdrawnAmputation; Traumatic, Hand | Amputation; Traumatic, Arm, Upper, Between Shoulder and Elbow | Amputation; Traumatic, Hand, Both | Amputation; Traumatic, Arm: Forearm, at Elbow Level | Amputation; Traumatic, Arm, UpperUnited States
-
OrthopusHandicap InternationalRecruitingWounds and Injuries | Amputation; Traumatic, Arm, Upper | Amputation; Traumatic, Hand, at Wrist Level | Amputation; Traumatic, Arm: ForearmNepal
-
Shirley Ryan AbilityLabUnited States Department of DefenseCompletedAmputation | Amputation; Traumatic, Arm, UpperUnited States
-
Point DesignsUniversity of Colorado, BoulderCompletedAmputation; Traumatic, Arm, UpperUnited States
-
Hacettepe UniversityCompleted
-
US Department of Veterans AffairsMassachusetts Institute of TechnologyCompletedTraumatic Amputation of Lower ExtremityUnited States
-
VA Eastern Colorado Health Care SystemCompletedTraumatic Amputation of Lower ExtremityUnited States
-
Alicia KoontzCompletedTraumatic Amputation of Lower ExtremityUnited States
Clinical Trials on upper extremity/ hand transplantation
-
Cairo UniversityCompleted
-
Riphah International UniversityRecruiting
-
US Department of Veterans AffairsMassachusetts Institute of TechnologyCompleted
-
NAİME ULUGCompletedChronic Kidney DiseasesTurkey
-
Maastricht University Medical CenterMaastricht University; VieCuri Medical Centre; Adelante, Centre of Expertise... and other collaboratorsCompleted
-
University of Illinois at ChicagoShirley Ryan AbilityLabCompletedStroke | Hemiparesis
-
Michael ReinhartLinkoeping University; Örebro University, Sweden; Region Örebro CountyCompletedHeart Diseases | Heart Diseases, Ischemic | Heart Disease, ValvularSweden
-
US Department of Veterans AffairsCompleted
-
Bezmialem Vakif UniversityCompletedMuscle Weakness | Coordination Lack | Hypermobility, JointTurkey
-
Gazi UniversityCompleted